| Dr Brian Emison Nicholson, MD | |
|
3612 23rd St, Lubbock, TX 79410-1326 | |
| (806) 793-8787 | |
| (806) 793-0150 |
| Full Name | Dr Brian Emison Nicholson |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 30 Years |
| Location | 3612 23rd St, Lubbock, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376541490 | NPI | - | NPPES |
| 178560201 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | L9397 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Covenant Medical Center | Lubbock, TX | Hospital |
| Grace Medical Center | Lubbock, TX | Hospital |
| Covenant Hospital Levelland | Levelland, TX | Hospital |
| Nor-lea Hospital District | Lovington, NM | Hospital |
| Covenant Childrens Hospital | Lubbock, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Covenant Medical Group | 6901889393 | 218 |
News Archive
Biogen Idec and Abbott today announced enrollment of the first patient in a global Phase III study evaluating the efficacy and safety of daclizumab compared to interferon beta-1a (AVONEX®) in patients with relapsing-remitting multiple sclerosis (RRMS), the most common form of multiple sclerosis (MS).
New research has revealed that while life expectancy in the United States has risen in the last decades not everyone has benefited from the increased long levity.
Shuaiyi International New Resources Development Inc. ("Shuaiyi" or the "Company"), a leading nutraceutical company focusing on the advanced technology related to the development of engineered "Cordyceps Militaris" in China, today announced the closing of a private placement with a group of accredited investors, pursuant to which the Company issued 1 million shares of the Company's common stock at a purchase price of $2.50 per share, for an aggregate purchase price of $2.5 million.
In the early days of the COVID-19 pandemic, the SARS-CoV-2 virus seemed only rarely to have serious complications in children.
› Verified 6 days ago
| Entity Name | Covenant Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376598904 PECOS PAC ID: 6901889393 Enrollment ID: O20040608000563 |
News Archive
Biogen Idec and Abbott today announced enrollment of the first patient in a global Phase III study evaluating the efficacy and safety of daclizumab compared to interferon beta-1a (AVONEX®) in patients with relapsing-remitting multiple sclerosis (RRMS), the most common form of multiple sclerosis (MS).
New research has revealed that while life expectancy in the United States has risen in the last decades not everyone has benefited from the increased long levity.
Shuaiyi International New Resources Development Inc. ("Shuaiyi" or the "Company"), a leading nutraceutical company focusing on the advanced technology related to the development of engineered "Cordyceps Militaris" in China, today announced the closing of a private placement with a group of accredited investors, pursuant to which the Company issued 1 million shares of the Company's common stock at a purchase price of $2.50 per share, for an aggregate purchase price of $2.5 million.
In the early days of the COVID-19 pandemic, the SARS-CoV-2 virus seemed only rarely to have serious complications in children.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Emison Nicholson, MD 3420 22nd Pl, Lubbock, TX 79410-1314 Ph: (806) 725-5844 | Dr Brian Emison Nicholson, MD 3612 23rd St, Lubbock, TX 79410-1326 Ph: (806) 793-8787 |
News Archive
Biogen Idec and Abbott today announced enrollment of the first patient in a global Phase III study evaluating the efficacy and safety of daclizumab compared to interferon beta-1a (AVONEX®) in patients with relapsing-remitting multiple sclerosis (RRMS), the most common form of multiple sclerosis (MS).
New research has revealed that while life expectancy in the United States has risen in the last decades not everyone has benefited from the increased long levity.
Shuaiyi International New Resources Development Inc. ("Shuaiyi" or the "Company"), a leading nutraceutical company focusing on the advanced technology related to the development of engineered "Cordyceps Militaris" in China, today announced the closing of a private placement with a group of accredited investors, pursuant to which the Company issued 1 million shares of the Company's common stock at a purchase price of $2.50 per share, for an aggregate purchase price of $2.5 million.
In the early days of the COVID-19 pandemic, the SARS-CoV-2 virus seemed only rarely to have serious complications in children.
› Verified 6 days ago
Dr. James Frederick Kirk, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3612 23rd St, Lubbock, TX 79410 Phone: 806-793-8787 Fax: 806-793-0150 | |
Dr. Thomas Nelius, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3502 9th St, Suite 260, Lubbock, TX 79415 Phone: 806-743-1810 Fax: 806-743-1335 | |
Chris H Brown, PA-C Urology Medicare: Accepting Medicare Assignments Practice Location: 6102 82nd St, Suite 5, Lubbock, TX 79424 Phone: 806-771-0077 Fax: 806-771-3175 | |
Carl Lee Britton Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 418 N Utica Ave, Lubbock, TX 79416 Phone: 806-771-5882 Fax: 806-687-9002 | |
Obie Lee Stalcup, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4515 Marsha Sharp Fwy, Lubbock, TX 79407 Phone: 806-744-7223 Fax: 806-740-3325 | |
Miss Jonathan S. Vordermark, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 3502 9th St, Suite 260, Lubbock, TX 79415 Phone: 806-743-1810 Fax: 806-743-1335 | |
Dr. Michael R Crone, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3601 4th St Stop 7260, Lubbock, TX 79430 Phone: 806-743-1810 Fax: 806-743-1335 |